BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 6161843)

  • 1. In vivo release of transmitters in the cat basal ganglia.
    Glowinski J
    Fed Proc; 1981 Feb; 40(2):135-41. PubMed ID: 6161843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptides in the basal ganglia.
    Graybiel AM
    Res Publ Assoc Res Nerv Ment Dis; 1986; 64():135-61. PubMed ID: 2425403
    [No Abstract]   [Full Text] [Related]  

  • 3. Release of dopamine in both caudate nuclei and both substantia nigrae in response to unilateral stimulation of cerebellar nuclei in the cat.
    Nieoullon A; Cheramy A; Glowinski J
    Brain Res; 1978 Jun; 148(1):143-52. PubMed ID: 656921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlordiazepoxide reduces in vivo serotonin release in the basal ganglia of encéphale isolé but not anesthetized cats: evidence for a dorsal raphe site of action.
    Soubrie P; Blas C; Ferron A; Glowinski J
    J Pharmacol Exp Ther; 1983 Aug; 226(2):526-32. PubMed ID: 6410048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in dopamine release in caudate nuclei and substantia nigrae after electrical stimulation of the posterior interposate nucleus of cat cerebellum.
    Nieoullon A; Dusticier N
    Neurosci Lett; 1980 Apr; 17(1-2):167-72. PubMed ID: 7052460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical interactions in the basal ganglia.
    McGeer PL; McGeer EG; Hattori T
    Prog Brain Res; 1979; 51():285-301. PubMed ID: 95234
    [No Abstract]   [Full Text] [Related]  

  • 7. Regulation of dopamine receptor and neuropeptide expression in the basal ganglia of monkeys treated with MPTP.
    Betarbet R; Greenamyre JT
    Exp Neurol; 2004 Oct; 189(2):393-403. PubMed ID: 15380489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo presynaptic control of dopamine release in the cat caudate nucleus--I. Opposite changes in neuronal activity and release evoked from thalamic motor nuclei.
    Romo R; Chéramy A; Godeheu G; Glowinski J
    Neuroscience; 1986 Dec; 19(4):1067-79. PubMed ID: 3029624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo release of [3H]GABA in cat caudate nucleus and substantia nigra. II. Involvement of different thalamic nuclei in the bilateral changes induced by a nigral application of muscimol.
    Kemel ML; Gauchy C; Glowinski J; Besson MJ
    Brain Res; 1984 Jun; 303(2):203-13. PubMed ID: 6331570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Origin of various enzymes released from the substantia nigra and caudate nucleus: effects of 6-hydroxydopamine lesions of the nigro-striatal pathway.
    Greenfield SA; Grünewald RA; Foley P; Shaw SG
    J Comp Neurol; 1983 Feb; 214(1):87-92. PubMed ID: 6404955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative involvement of globus pallidus and subthalamic nucleus in the regulation of somatodendritic dopamine release in substantia nigra is dopamine-dependent.
    Cobb WS; Abercrombie ED
    Neuroscience; 2003; 119(3):777-86. PubMed ID: 12809698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of in vivo nigral 5HT release in the cat.
    Reisine TD; Soubrie P; Bourgoin S; Artaud F; Glowinski J
    Adv Biochem Psychopharmacol; 1983; 36():91-101. PubMed ID: 6190361
    [No Abstract]   [Full Text] [Related]  

  • 13. In vivo release of newly synthesized GABA in the basal ganglia of the cat.
    Gauchy C; Kemel ML; Glowinski J; Besson MJ
    Adv Biochem Psychopharmacol; 1981; 29():183-91. PubMed ID: 7257927
    [No Abstract]   [Full Text] [Related]  

  • 14. Changes of amino acid and monoamine levels after neonatal 6-hydroxydopamine denervation in rat basal ganglia, substantia nigra, and Raphe nuclei.
    Molina-Holgado E; Dewar KM; Grondin L; van Gelder NM; Reader TA
    J Neurosci Res; 1993 Jul; 35(4):409-18. PubMed ID: 8360949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the thalamus in the bilateral regulation of dopaminergic and GABAergic neurons in the basal ganglia.
    Glowinski J; Besson MJ; Chéramy A
    Ciba Found Symp; 1984; 107():150-63. PubMed ID: 6094123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Release of dopamine evoked by electrical stimulation of the motor and visual areas of the cerebral cortex in both caudate nuclei and in the substantia nigra in the cat.
    Nieoullon A; Cheramy A; Glowinski J
    Brain Res; 1978 Apr; 145(1):69-83. PubMed ID: 638784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo release of endogenously synthesized [3H]GABA from the cat substantia nigra and the pallido-entopeduncular nuclei.
    Gauchy C; Kemel ML; Glowinski J; Besson MJ
    Brain Res; 1980 Jul; 193(1):129-41. PubMed ID: 7378813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of release processes in central serotoninergic neurons.
    Héry F; Ternaux JP
    J Physiol (Paris); 1981; 77(2-3):287-301. PubMed ID: 6457140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symmetric bilateral changes in dopamine release from the caudate nuclei of the cat induced by unilateral nigral application of glycine and GABA-related compounds.
    Leviel V; Chéramy A; Nieoullon A; Glowinski J
    Brain Res; 1979 Oct; 175(2):259-70. PubMed ID: 487156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine released from dendrites in the substantia nigra controls the nigral and striatal release of serotonin.
    Hery F; Soubrie P; Bourgoin S; Motastruc JL; Artaud F; Glowinski J
    Brain Res; 1980 Jul; 193(1):143-51. PubMed ID: 6247027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.